dc.creator | Rosaneli, C F | |
dc.creator | Bighetti, A E | |
dc.creator | Antônio, M A | |
dc.creator | Carvalho, J E | |
dc.creator | Sgarbieri, V C | |
dc.date | 2004 | |
dc.date | 2015-11-27T12:58:27Z | |
dc.date | 2015-11-27T12:58:27Z | |
dc.date.accessioned | 2018-03-29T00:59:38Z | |
dc.date.available | 2018-03-29T00:59:38Z | |
dc.identifier | Journal Of Medicinal Food. v. 7, n. 3, p. 309-14, 2004. | |
dc.identifier | 1096-620X | |
dc.identifier | 10.1089/1096620041938722 | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/15383224 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/195956 | |
dc.identifier | 15383224 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1296189 | |
dc.description | The protective effect of a whey protein concentrate (WPC) was studied in three models of stomach ulcerative lesions induction: subcutaneous injection of indomethacin, and stress induced by either intraperitoneal injection of reserpine, or immobilization and holding in the cold (4 degrees C, 2 hours). Adult Wistar rats (300-400 g) were used for acute (single-dose), repetitive, or subchronic (10 days) administration of WPC prior to treatment with the ulcerogenic factors. The best protection was achieved in the indomethacin model for repetitive and subchronic experiments, reaching 50.1% and 44%, respectively, inhibition of the ulcerative lesions, which was significant at 1% probability (P <.01). For the immobilization and cold model, maximum inhibition by WPC was 22.1%, and that for the reserpine model was 23.8%. In both models the inhibition was not significant (P >.05) compared with saline (negative control). | |
dc.description | 7 | |
dc.description | 309-14 | |
dc.language | eng | |
dc.relation | Journal Of Medicinal Food | |
dc.relation | J Med Food | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Animals | |
dc.subject | Anti-inflammatory Agents, Non-steroidal | |
dc.subject | Anti-ulcer Agents | |
dc.subject | Cattle | |
dc.subject | Cimetidine | |
dc.subject | Disease Models, Animal | |
dc.subject | Gastric Mucosa | |
dc.subject | Immobilization | |
dc.subject | Indomethacin | |
dc.subject | Injections, Intraperitoneal | |
dc.subject | Injections, Subcutaneous | |
dc.subject | Male | |
dc.subject | Milk | |
dc.subject | Milk Proteins | |
dc.subject | Random Allocation | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Reserpine | |
dc.subject | Stomach Ulcer | |
dc.title | Protective Effect Of Bovine Milk Whey Protein Concentrate On The Ulcerative Lesions Caused By Subcutaneous Administration Of Indomethacin. | |
dc.type | Artículos de revistas | |